The key factors which are closely linked with tumor microenvironment (TME) metabolic alterations in RCC include HIF, fatty acid synthase (FASN) and pyruvate kinase 2 (PKM2), being potential targets in cancer therapy (10). This evidence concerns the gene FASN and cancer.